[Federal Register Volume 85, Number 199 (Wednesday, October 14, 2020)]
[Notices]
[Page 65075]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-22692]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-729]


Bulk Manufacturer of Controlled Substances Application: Euticals, 
Inc.

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Euticals Inc. has applied to be registered as a bulk 
manufacturer of basic class(es) of controlled substance(s). Refer to 
Supplemental Information listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before December 14, 
2020. Such persons may also file a written request for a hearing on the 
application on or before December 14, 2020.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on September 21, 2020, Euticals Inc., 2460 West Bennett 
Street, Springfield, Missouri 65807-1229, applied to be registered as 
an bulk manufacturer of the following basic class(es) of controlled 
substance(s):

------------------------------------------------------------------------
              Controlled substance                 Drug code   Schedule
------------------------------------------------------------------------
Marihuana.......................................       7360           I
------------------------------------------------------------------------

    The company plans to manufacture synthetic Cannabidiol to be 
distributed as an Active Pharmaceutical Ingredient (API) to its 
customers. No other activity for these drug codes is authorized for 
this registration.

William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-22692 Filed 10-13-20; 8:45 am]
BILLING CODE P